Beginning of Effective and Safe Treatment in Immunoglobulin A-1 Nephropathy-1
about
Beginning of Effective and Safe Treatment in Immunoglobulin A-1 Nephropathy-1
description
clinical trial
@en
klinisch onderzoek
@nl
name
Beginning of Effective and Safe Treatment in Immunoglobulin A-1 Nephropathy-1
@en
type
label
Beginning of Effective and Safe Treatment in Immunoglobulin A-1 Nephropathy-1
@en
prefLabel
Beginning of Effective and Safe Treatment in Immunoglobulin A-1 Nephropathy-1
@en
P767
P1050
P1476
A Randomized, Double Blinded, ...... A Nephropathy (IgAN) Patients
@en
P1813
BEST-IgAN-1
@en
P3098
NCT03357653
P4844
P580
2018-01-30T00:00:00Z
P582
2021-12-31T00:00:00Z